Technavio Announces Key Highlights From Their Needle Free Drug Delivery, Antiemetic Drugs, and Scleroderma Treatment Reports

Technavio's healthcare and life sciences industry reports cover a variety of markets. (Graphic: Business Wire)

LONDON--()--Technavio’s research analysts have recently completed numerous reports analyzing the latest market opportunities, trends, and developments in the global healthcare and life sciences industry. Per Technavio's recent market findings, the progression of the healthcare industry towards efficient and cost-effective healthcare solutions has had a huge impact on the medical devices, life sciences, and pharmaceutical sectors.

Technavio has compiled a list of three markets that have high growth potential for the forecast period of 2017-2021. All three of these reports are currently available at a USD 1,000 discount for a limited time only. To access all of Technavio’s reports, request a free demo to see how you can view the full library which consists of 8,000+ reports.

Key Highlights from Technavio

Global Needle Free Drug Delivery Market 2017-2021

This report is available at a USD 1,000 discount: View market snapshot before purchasing

  • The global needle free drug delivery market is estimated to grow due to the rising demand for new biopharmaceutical drugs, mandatory use of needle-free drug delivery devices, and increasing self-administration.
  • The advances in technology have made needle-free drug delivery devices ergonomic and portable, thereby eliminating the possibility of needle stick injuries.
  • The market is expected to grow significantly during the forecast period as the market players are investing considerable resources in R&D and technological innovations.

Global Antiemetic Drugs Market 2017-2021

This report is available at a USD 1,000 discount: View market snapshot before purchasing

  • There is a wide application spectrum of antiemetic drugs, which include treating various disease symptoms or treating side effects associated with drug treatment.
  • The usage of antiemetic drugs to treat postoperative nausea and vomiting (PONV) due to analgesics and anesthesia is fueling the market in recent years.
  • The global antiemetic drugs market is mainly controlled by key vendors such as GlaxoSmithKline, Pfizer, Johnson & Johnson, Eli Lilly, Sanofi, and Novartis.

Global Scleroderma Treatment Market 2017-2021

This report is available at a USD 1,000 discount: View market snapshot before purchasing

  • The upcoming market research report on the global scleroderma treatment market offers insights into the key market drivers, trends, and eminent challenges that will influence the growth of the key suppliers in this market space.
  • This report covers vendors like GSK, MedImmune, Roche, Fibrocell, and Vivacell.
  • The report also presents intelligence into the changing competitive landscape and gives clients a holistic view of the future direction of the industry.

Access Technavio’s Full Report Library

Technavio subscription plans start at USD 10,000 annually. Subscribing to this plan will give you immediate access to new reports as they’re published in addition to all 8,000+ existing reports in 120+ industries and 50+ countries. Request a free demo to learn more about this offer.

Browse other reports from our healthcare and life sciences library:

About Technavio

Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.

Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, resellers, and end-users.

If you are interested in more information, please contact our media team at media@technavio.com.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com

Release Summary

Technavio announces key highlights from their needle free drug delivery, antiemetic drugs, and scleroderma treatment reports.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com